I just published a paper in Stem Cells Translational Medicine on my experience traveling to and attending a stem cell clinic patient recruitment seminar. It was an intense experience and one where I felt at risk. To some extent it is akin to going into the lion’s den. I didn’t know what reaction I would […]
The stem cell hard sell: my new paper in Stem Cells Translational Medicine Read More »
By Gaetan Burgio CRISPR/Cas9 genome editing has dramatically changed our way to perform biological experiments. While highly efficient and easy to use, one limitation with CRISPR/Cas9 mediated genome editing technology is the occurrence of off-target effects and the restriction of the PAM recognition sequence. Many modifications from the original system have been proposed to improve
Gaetan Burgio New Data & Theory on NgAgo versus CRISPR Read More »
Has it really been 10 years since induced pluripotent stem cells (aka IPS cells or IPSC) came onto the scene in the stem cell field? Yes, it was a decade ago that now Nobel Laureate Shinya Yamanaka (山中伸弥) published that seminal Cell paper on reprogramming to make mouse IPS cells and then human IPS cells
Yamanaka’s baby turns 10: ten IPS cell hot button bullet points Read More »
CIRM announced recently the funding of a number of exciting new studies. ViaCyte received additional funding to support its development of its hESC-based pancreatic progenitor cell product PEC-Direct clinic trials. This work is very promising. CIRM also funded additional diabetes-related research by Humacyte on engineering blood vessels for use in dialysis, which is very creative. I
Stem cell good news: CIRM funds new cutting edge studies Read More »
Here is the Stem Cell Clinic List Database file from Turner & Knoepfler, Cell Stem Cell 2016 paper. Note that this list is not intended to be used for commercial purposes. Inclusion of any particular business on this list is not meant as an endorsement or criticism. General considerations. There are overall many reasons for exercising
Stem Cell Clinic List Database Read More »
The local stem cell clinic here in Sacramento, Nervana Stem Cell Centers, continues to advertise treatments in The Sacramento Bee and there continue to be big questions about this situation. I’ve blogged about Nervana before and you can see the archived posts here. Nervana must be spending big money on advertising because they have run many
Nervana stem cell clinic: big ads in SacBee & big questions continue Read More »
Professor Rudolf Jaenisch of MIT and his former postdoc/now assistant professor at The Weizmann Jacob Hanna have gotten into a very public, stem cell skirmish over conflicting papers. Hanna raised concerns over a Jaenisch lab paper and things have escalated from there. This mess is playing out before our eyes on PubMed (there was a comment from Hanna
Public stem cell skirmish erupts between Hanna & Jaenisch Read More »
That much-anticipated public FDA stem cell meeting that was postponed from April will now take place in September and will have a much larger array of diverse speakers. Many more voices at an FDA stem cell meeting are collectively a good thing, but delay is not. The large and growing U.S. stem cell clinic industry makes
September FDA stem cell meeting looks to be big debate Read More »
You can listen to my co-author Leigh Turner’s interview on Science Friday here about our Cell Stem Cell paper on the stem cell clinic industry in the U.S. Start listening around the 8:30 mark. It’s great that this paper has so strongly raised awareness about the booming stem cell clinic industry in America as well
Listen to Leigh Turner’s interview on Science Friday on our stem cell clinic paper Read More »
Each December I make stem cell predictions for the coming year and I did that for 2016 where I made 20 predictions. At around mid year I do a checkup on how my predictions are doing halfway and that is the purpose of this post. Below are my predictions that I made in 2015 for stem
Stem cell checkup: how are my 2016 predictions doing half way? Read More »